Corcept Therapeutics, Inc. (CORT)
32.15
-0.24
(-0.74%)
USD |
NASDAQ |
Mar 13, 16:00
32.17
+0.02
(+0.06%)
After-Hours: 20:00
Corcept Therapeutics Total Liabilities (Quarterly) : 190.22M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | 601.51M |
| Alphatec Holdings, Inc. | 755.18M |
| Harrow, Inc. | 353.12M |
| Ultragenyx Pharmaceutical, Inc. | 1.605B |
| Amneal Pharmaceuticals, Inc. | 3.672B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 838.03M |
| Shareholders Equity (Quarterly) | 647.80M |
| Debt to Equity Ratio | 0.0094 |
| Current Ratio | 2.892 |
| Net Debt Paydown Yield | 0.00% |